Advances on the mechanisms of metformin in improving cognitive impairment in schizophrenia
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2024, Vol 50, Issue 5
Abstract
Schizophrenia is a common chronic mental disorder. Cognitive dysfunction is one of its core symptoms , which severely affects the social functioning of patients. Currently, antipsychotic medication treatments have poor efficacy in improving cognitive functions. Recent studies have found that metformin can improve cognitive dysfunction in patients with schizophrenia. However, the mechanism of action remains unclear. This review summarizes the therapeutic effects of metformin on cognitive dysfunction in schizophrenia patients such as improving insulin resistance, repairing neuronal damage, regulating neuroimmunity, and combating oxidative stress, thereby providing new insights for the treatment of cognitive dysfunction in schizophrenia.
Authors and Affiliations
Houming ZHU, Cuicui CUI, Weili XIA, Jiacui JI, Hongchang ZHANG, Xianbiao SU, Zhongbao WANG, Jiashu MA, Haoran CHU, Yunshao ZHENG, Ludong BAI, Ranran. LI
Keywords
Related Articles
- EP ID EP750497
- DOI 10.3969/j.issn.1002-0152.2024.05.012
- Views 1
- Downloads 0
Research progress on the application of light therapy in patients with bipolar depression
Existing antidepressant treatments are generally suboptimal for patients with bipolar disorder (BD). Several studies have explored the efficacy of light therapy (LT) in patients with bipolar depression, along with invest...
Research progress on multiple mechanisms underlying visual hallucinations in schizophrenia patients
Visual hallucination (VH) is a common symptom of schizophrenia, the underlying mechanism has not been fully elucidated. It has been found that the dysfunction of dopamine (DA) system, the overactivation of α-amino-3-hydr...
Study of the correlation between red blood cell distribution width，systemic immune-inflammation index with major depressive disorder
[Objective] To investigate the correlation between red blood cell distribution width (RDW), systemic immune-inflammation index (SII) and major depressive disorder (MDD). [Methods] The clinical data of 176 MDD patients ho...
Research progress of cognitive impairment in patients with attenuated psychosis syndrome
Attenuated psychosis syndrome (APS) is a clinical disorder associated with a high risk of psychosis. Patients during this period typically exhibit multidimensional neurocognitive and social cognitive impairment. Cognitiv...
Mid-to-long-term quality of life and psychological status after endovascular embolization of unruptured intracranial aneurysms
[Objective] To investigate whether embolization surgery can improve mid-to-long-term outcomes related to quality of life, anxiety and depression in patients with unruptured intracranial aneurysms (UIA). [Methods] This pr...